Previous 10 | Next 10 |
Presentation hosted by Dr. Michael Kluska to feature the results of a retrospective clinical study comparing the use of Renuvion to a competing technology when used in conjunction with liposuction or body contouring, demonstrating significantly fewer adverse events Apyx Medical Corporat...
2024-02-20 16:59:25 ET Gainers: Apyx Medical ( APYX ) +8% . Intuitive Machines ( LUNR ) +6% . Enovix Corporation ( ENVX ) +6% . Iridium Communications ( IRDM ) +3% . Halozyme Therapeutics ( HALO ) +3% . Losers: Sola...
2024-01-22 16:20:27 ET More on Apyx Medical Apyx Medical Corporation (APYX) Q3 2023 Earnings Call Transcript Apyx Medical's Q4 revenue to be below consensus Apyx Medical appoints Matthew Hill as CFO Seeking Alpha’s Quant Rating on Apyx Medical ...
Analysis of data from 483 patients with a total of 1,184 body areas treated found the use of Renuvion for subcutaneous soft tissue contraction following liposuction demonstrated no new or increased risks for any area of the body, compared to the use of liposuction alone Apyx Medical Cor...
2024-01-15 15:49:19 ET More on Align Technology, DexCom, etc. Intuitive Surgical: Strong Pre-Announced Q4 - Time To Harvest The Gain, Initiate With 'Sell' Intuitive Surgical, Inc. (ISRG) JPMorgan Healthcare Conference Call Transcript Intuitive Surgical: Sustained Gro...
2024-01-08 12:17:43 ET More on Apyx Medical Apyx Medical Corporation (APYX) Q3 2023 Earnings Call Transcript Apyx Medical appoints Matthew Hill as CFO Apyx Medical announces new debt facility with Perceptive Advisors Seeking Alpha’s Quant Rating on Apy...
Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion ® , today reported preliminary revenue results for the fourth quarter and full year ended December 31, 2023....
2023-12-14 11:55:06 ET More on Apyx Medical Apyx Medical Corporation (APYX) Q3 2023 Earnings Call Transcript Apyx Medical appoints Matthew Hill as CFO For further details see: Apyx Medical finance chief buys 2.5K common shares
2023-11-28 08:52:18 ET More on Apyx Medical, Precision Drilling, etc. Precision Drilling: Bullish On Canadian Oilfield Services Stocks Going Into 2024 STRATA Skin Sciences GAAP EPS of -$0.03 beats by $0.01, revenue of $8.85M beats by $0.13M Apyx Medical announces new...
Apyx Medical Corporation (Nasdaq:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today announced the appointment of Matthew Hill to the position of Chief Financial...
News, Short Squeeze, Breakout and More Instantly...
Apyx Medical Corporation Company Name:
APYX Stock Symbol:
NASDAQ Market:
Apyx Medical Corporation Website:
Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion ® , today announced that financial results for the first quarter of fiscal year 2024 will be released before...
Shaping the Future of Aesthetic Treatments with Advanced Medical Technology Apyx® Medical Corporation (NASDAQ:APYX) (the “Apyx Medical”; “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvi...
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 300 points on Thursday. The Dow traded up 0.77% to 39,...